Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photobiomodulation for Vulvovaginal Atrophy
NCT04487392Phase 2Withdrawn
- Sponsor
- University of Nove de Julho
- Start
- Dec 2020
- Primary completion
- Sep 2021
01
Overview
Phase 2, randomised, open-label trial in Vulvovaginal atrophy (VVA) (2 arms), sponsored by University of Nove de Julho. Primary endpoints: Vaginal Health Index at 6 months and Visual Analog Scale at 6 months. Planned start Dec 2020; status: withdrawn.
02
Conditions
Vulvovaginal atrophy (VVA)
Beyond the preview
Go deeper on NCT04487392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04487392.